We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+24.55%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$8.79B
AUM Growth
+$1.45B
Cap. Flow
-$72.5M
Cap. Flow %
-0.82%
Top 10 Hldgs %
20.48%
Holding
2,420
New
180
Increased
1,163
Reduced
213
Closed
125

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$8.64M
2
WORK
Slack Technologies, Inc.
WORK
+$7.6M
3
ABBV icon
AbbVie
ABBV
+$7.02M
4
TMUS icon
T-Mobile US
TMUS
+$6.46M
5
OTIS icon
Otis Worldwide
OTIS
+$5.52M

Sector Composition

Rank Sector Weight
1 Technology 21.58%
2 Healthcare 14.02%
3 Financials 12.88%
4 Consumer Discretionary 10.4%
5 Industrials 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FAF icon
501
First American
FAF
$7.44B
$3.18M 0.04%
66,167
+1,685
+3% +$79.6K
JLL icon
502
Jones Lang LaSalle
JLL
$16.7B
$3.17M 0.04%
30,661
+1,079
+4% +$111K
CLGX
503
DELISTED
Corelogic, Inc.
CLGX
$3.17M 0.04%
47,158
+1,514
+3% +$67.3K
PII icon
504
Polaris
PII
$3.93B
$3.16M 0.04%
34,191
+1,184
+4% +$90.2K
UTHR icon
505
United Therapeutics
UTHR
$21.7B
$3.16M 0.04%
26,137
+949
+4% +$107K
RGA icon
506
Reinsurance Group of America
RGA
$16.1B
$3.16M 0.04%
40,276
+4,336
+12% +$400K
ATO icon
507
Atmos Energy
ATO
$28.7B
$3.16M 0.04%
31,720
+958
+3% +$96.6K
SJM icon
508
J.M. Smucker
SJM
$12.8B
$3.16M 0.04%
29,824
+425
+1% +$47.8K
SMG icon
509
ScottsMiracle-Gro
SMG
$3.6B
$3.15M 0.04%
23,402
+659
+3% +$85.1K
STOR
510
DELISTED
STORE Capital Corporation
STOR
$3.15M 0.04%
+132,132
New +$2.64M
SHLX
511
DELISTED
Shell Midstream Partners, L.P.
SHLX
$3.15M 0.04%
256,388
TXNM
512
TXNM Energy Inc
TXNM
$5.91B
$3.14M 0.04%
81,752
+1,580
+2% +$63.1K
EXR icon
513
Extra Space Storage
EXR
$31.4B
$3.12M 0.04%
33,760
+377
+1% +$35K
PCTY icon
514
Paylocity
PCTY
$7.69B
$3.12M 0.04%
+21,361
New +$2.49M
IEX icon
515
IDEX
IEX
$17.6B
$3.12M 0.04%
19,717
+112
+0.6% +$17.1K
SON icon
516
Sonoco
SON
$5.75B
$3.12M 0.04%
59,580
+2,123
+4% +$105K
SYF icon
517
Synchrony
SYF
$25.8B
$3.11M 0.04%
140,447
-5,034
-3% -$98.1K
KEY icon
518
KeyCorp
KEY
$24.6B
$3.11M 0.04%
255,108
+1,220
+0.5% +$14.2K
MZTI
519
The Marzetti Company
MZTI
$3.23B
$3.1M 0.04%
19,998
+823
+4% +$120K
LNT icon
520
Alliant Energy
LNT
$18.3B
$3.1M 0.04%
64,706
+2,753
+4% +$134K
SAM icon
521
Boston Beer
SAM
$1.9B
$3.08M 0.04%
5,735
-3,050
-35% -$1.48M
SBRA icon
522
Sabra Healthcare REIT
SBRA
$5.21B
$3.08M 0.04%
213,274
+9,437
+5% +$124K
UBS icon
523
UBS Group
UBS
$175B
$3.07M 0.03%
267,399
-1,607
-0.6% -$16.6K
OMC icon
524
Omnicom Group
OMC
$23.7B
$3.06M 0.03%
56,042
-81
-0.1% -$4.41K
XYL icon
525
Xylem
XYL
$28B
$3.06M 0.03%
47,053
+636
+1% +$42K

Similar funds

MetLife Investment Management's Q2 2020 Portfolio in Review

As of Q2 2020, MetLife Investment Management held 2,420 positions worth $8.79B, up 20% from $7.34B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

MetLife Investment Management's Q2 2020 filing shows 180 new, 1,163 increased, 213 reduced and 125 closed positions. Its largest new stake was DexCom: 96,564 shares worth $9.79M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $143M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q2 2020 buy was DexCom: 96,564 shares worth $9.79M.
  • MetLife Investment Management added most to AbbVie in Q2 2020, an estimated $7.02M increase.
  • MetLife Investment Management's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $143M.
  • MetLife Investment Management fully exited Allergan plc in Q2 2020, selling an estimated $15M.
  • MetLife Investment Management's ten largest holdings make up 20% of its $8.79B portfolio in Q2 2020.
  • MetLife Investment Management opened 180 new positions and closed 125 in Q2 2020.
  • MetLife Investment Management's portfolio value rose 20% quarter-over-quarter to $8.79B.

Based on MetLife Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.